Evidence map›Paper›PMID 38840030›Full record

GuidelineBritish journal of cancer2025

Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines.

Ian Judson, Robin L Jones, Newton A C S Wong, Palma Dileo, Ramesh Bulusu, Myles Smith, Max Almond

Abstract readPractice GuidelineReview
In one paragraph

Guideline in British journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ian JudsonThe Institute of Cancer Research, London, UK. Ian.Judson@icr.ac.uk.ORCID 0000-0002-4766-5304
Robin L JonesRoyal Marsden NHS Foundation Trust, London, UK.ORCID 0000-0003-4173-3844
Newton A C S WongSouthmead Hospital, Bristol, UK.
Palma DileoUniversity College Hospital, London, UK.
Ramesh BulusuAddenbrooke's Hospital, Cambridge, UK.
Myles SmithRoyal Marsden NHS Foundation Trust, London, UK.
Max AlmondBirmingham University Hospitals, Birmingham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBritish Sarcoma Group guidelines for the management of GIST were initially informed by those published by the European Society of Clinical Oncology. This update was written by a group of experts to includes a discussion of the highlight improvements in our knowledge of the disease and recent treatment developments. The guidelines include sections on Incidence, Aetiology, Diagnosis, including risk assessment, Treatment and Follow-up.

methodsA careful review of the literature was performed to ensure that wherever possible recommendations are supported by the results of clinical trials or substantive retrospective reports. Areas of uncertainty are indicated appropriately.

conclusionGuidelines represent a consensus view of current best clinical practice. Where appropriate, key recommendations are given and the levels of evidence and strength of recommendation gradings are those used by the European Society for Medical Oncology (ESMO).

Indexed as

Gastrointestinal NeoplasmsGastrointestinal Stromal TumorsHumansUnited Kingdom

Identifiers

PMID38840030
PMCPMC11723931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.